Superoxide dismutase
Alternative Names: SI 3501Latest Information Update: 07 Jan 2022
At a glance
- Originator Chiron Corporation; Seikagaku Corporation
- Class Anti-inflammatories; Anti-ischaemics; Antirheumatics; Oxidoreductases
- Mechanism of Action Superoxide dismutase replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Inflammation; Osteoarthritis